Fundraising Fox

Adagio Therapeutics

NASDAQ: IVVD

Waltham, US · Founded 2020 · Delaware corporation · 3 known investors

Biotech

Founders & leadership

LC
Lynn ConnollyExecutive Officer
EK
Eric KimbleExecutive Officer
HG
Halley GilbertExecutive Officer
TM
Terrance McGuireDirector
RD
Rebecca DaboraExecutive Officer
RR
Rene RussoDirector
HM
Howard MayerDirector
PC
Philip ChaseDirector
EH
Ellie HershbergerExecutive Officer
AR
Ajay RoyanDirector
TU
Tillman U. GerngrossExecutive Officer, Director
JH
Jane HendersonExecutive Officer

Investors · 3

Mithril Capital ManagementreportedAustinvia Ajay Royan · board
Polaris PartnersreportedBoston · $500K – $5Mvia Terry McGuire · board
Veltro ArgentoreportedStamford

Reported raises · per SEC filings

Form D private placements
▶$23.7MraisedNov 2022 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Michael S. WyzgaDirector
  • Fred DriscollExecutive Officer
  • Tamsin BerryDirector
  • Christine LindenboomDirector
  • Terry McGuireDirector
  • Rebecca DaboraExecutive Officer
  • Marc EliaDirector
  • Jill AndersenExecutive Officer
  • Clive A. MeanwellDirector
  • David HeringExecutive Officer, Director
  • Ellie HershbergerExecutive Officer
  • Tom HeymanDirector
Offering amount
$23.7M
Amount sold
$23.7M
First sale
Nov 2022
Incorporated
Corporation, Delaware, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$335.5MraisedApr 2021 · 36 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Lynn ConnollyExecutive Officer
  • Eric KimbleExecutive Officer
  • Halley GilbertExecutive Officer
  • Terrance McGuireDirector
  • Rebecca DaboraExecutive Officer
  • Rene RussoDirector
  • Howard MayerDirector
  • Philip ChaseDirector
  • Ellie HershbergerExecutive Officer
  • Ajay RoyanDirector
  • Tillman U. GerngrossExecutive Officer, Director
  • Jane HendersonExecutive Officer
  • Laura WalkerExecutive Officer
Offering amount
$335.5M
Amount sold
$335.5M
First sale
Apr 2021
Incorporated
Corporation, Delaware, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$80MraisedNov 2020 · 16 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Halley GilbertExecutive Officer
  • Howard MayerDirector
  • Marc EliaDirector
  • Rene RussoDirector
  • Terrance G. McGuireDirector
  • Ajay RoyanDirector
  • Philip T. ChaseDirector
  • Tillman U. GerngrossExecutive Officer, Director
Offering amount
$80M
Amount sold
$80M
First sale
Oct 2020
Incorporated
Corporation, Delaware, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$49.9MraisedNov 2020 · 24 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Halley GilbertExecutive Officer
  • Terrance G. McGuireDirector
  • Rene RussoDirector
  • Marc EliaDirector
  • Philip T. ChaseDirector
  • Tillman U. GerngrossExecutive Officer, Director
  • Ajay RoyanDirector
  • Howard MayerDirector
Offering amount
$49.9M
Amount sold
$49.9M
First sale
Jul 2020
Incorporated
Corporation, Delaware, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.